Cell Communication and Signaling,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Sept. 19, 2022
Abstract
Background
Exosomes
are
progressively
known
as
significant
mediators
of
cell-to-cell
communication.
They
convey
active
biomolecules
to
target
cells
and
have
vital
functions
in
several
physiological
pathological
processes,
show
substantial
promise
novel
treatment
strategies
for
diseases.
Methods
In
this
review
study,
we
studied
numerous
articles
over
the
past
two
decades
published
on
application
exosomes
different
diseases
well
perspective
challenges
field.
Results
The
main
clinical
using
them
a
biomarker,
cell-free
therapeutic
agents,
drug
delivery
carriers,
basic
analysis
exosome
kinetics,
cancer
vaccine.
Different
from
human
or
plant
sources
utilized
various
trials.
Most
researchers
used
circulatory
system
biomarker
experiments.
Mesenchymal
stem
(MSCs)
dendritic
(DCs)
widely
held
cell
use.
MSCs-derived
commonly
inflammation
delivery,
while
DCs-exosomes
induce
response
patients.
However,
faces
questions
challenges.
addition,
translation
exosome-based
trials
is
required
conform
specific
good
manufacturing
practices
(GMP).
review,
summarize
according
type
disease.
We
also
address
regarding
kinetics
applications.
Conclusions
promising
platforms
many
This
exciting
field
developing
hastily,
understanding
underlying
mechanisms
that
direct
observed
roles
remains
far
complete
needs
further
multidisciplinary
research
working
with
these
small
vesicles.
Cells,
Journal Year:
2019,
Volume and Issue:
8(7), P. 727 - 727
Published: July 15, 2019
The
use
of
extracellular
vesicles,
specifically
exosomes,
as
carriers
biomarkers
in
spaces
has
been
well
demonstrated.
Despite
their
promising
potential,
the
exosomes
clinical
setting
is
restricted
due
to
lack
standardization
exosome
isolation
and
analysis
methods.
purpose
this
review
not
only
introduce
different
types
vesicles
but
also
summarize
differences
similarities,
discuss
methods
currently
used.
A
thorough
understanding
being
used
could
lead
some
field
exosomal
research,
allowing
become
a
reality.
Cell & Bioscience,
Journal Year:
2019,
Volume and Issue:
9(1)
Published: Feb. 15, 2019
Exosomes
are
nano-sized
biovesicles
released
into
surrounding
body
fluids
upon
fusion
of
multivesicular
bodies
and
the
plasma
membrane.
They
were
shown
to
carry
cell-specific
cargos
proteins,
lipids,
genetic
materials,
can
be
selectively
taken
up
by
neighboring
or
distant
cells
far
from
their
release,
reprogramming
recipient
bioactive
compounds.
Therefore,
regulated
formation
exosomes,
specific
makeup
cargo,
cell-targeting
specificity
immense
biological
interest
considering
extremely
high
potential
exosomes
as
non-invasive
diagnostic
biomarkers,
well
therapeutic
nanocarriers.
In
present
review,
we
outline
discuss
recent
progress
in
elucidation
regulatory
mechanisms
exosome
biogenesis,
molecular
composition
technologies
used
research.
Furthermore,
focus
on
use
valuable
prognostic
biomarkers
for
cell-lineage
state-specific
contents,
possibilities
vehicles
drug
gene
delivery.
Exosome
research
is
now
its
infancy,
in-depth
understanding
subcellular
components
involved
will
bring
light
physiological
activities.
Theranostics,
Journal Year:
2017,
Volume and Issue:
7(3), P. 789 - 804
Published: Jan. 1, 2017
Exosomes
are
one
type
of
membrane
vesicles
secreted
into
extracellular
space
by
most
types
cells.
In
addition
to
performing
many
biological
functions
particularly
in
cell-cell
communication,
cumulative
evidence
has
suggested
that
several
entities
exosomes
like
proteins
and
microRNAs
closely
associated
with
the
pathogenesis
human
malignancies
they
may
serve
as
invaluable
biomarkers
for
disease
diagnosis,
prognosis,
therapy.
This
provides
a
commanding
impetus
growing
demands
simple,
efficient,
affordable
techniques
isolate
exosomes.
Capitalizing
on
physicochemical
biochemical
properties
exosomes,
number
have
been
developed
isolation
article
summarizes
advances
exosome
an
emphasis
their
mechanism,
performance,
challenges,
prospects.
We
hope
this
will
provide
overview
techniques,
opening
up
new
perspectives
towards
development
more
innovative
strategies
devices
time
saving,
cost
effective,
efficient
isolations
from
wide
range
matrices.
Acta Pharmaceutica Sinica B,
Journal Year:
2016,
Volume and Issue:
6(4), P. 287 - 296
Published: March 9, 2016
Exosomes
are
small
intracellular
membrane-based
vesicles
with
different
compositions
that
involved
in
several
biological
and
pathological
processes.
The
exploitation
of
exosomes
as
drug
delivery
vehicles
offers
important
advantages
compared
to
other
nanoparticulate
systems
such
liposomes
polymeric
nanoparticles;
non-immunogenic
nature
due
similar
composition
body׳s
own
cells.
In
this
article,
the
origin
structure
well
their
functions
outlined.
We
will
then
focus
on
specific
applications
pharmaceutical
development.
An
overview
challenges
faced
when
using
a
also
be
discussed.
Theranostics,
Journal Year:
2021,
Volume and Issue:
11(7), P. 3183 - 3195
Published: Jan. 1, 2021
Exosomes
are
cell-derived
nanovesicles
that
involved
in
the
intercellular
transportation
of
materials.
Therapeutics,
such
as
small
molecules
or
nucleic
acid
drugs,
can
be
incorporated
into
exosomes
and
then
delivered
to
specific
types
cells
tissues
realize
targeted
drug
delivery.
Targeted
delivery
increases
local
concentration
therapeutics
minimizes
side
effects.
Here,
we
present
a
detailed
review
engineering
through
genetic
chemical
methods
for
Although
still
its
infancy,
exosome-mediated
boasts
low
toxicity,
immunogenicity,
high
engineerability,
holds
promise
cell-free
therapies
wide
range
diseases.
Acta Pharmacologica Sinica,
Journal Year:
2017,
Volume and Issue:
38(6), P. 754 - 763
Published: April 10, 2017
Exosomes,
a
subgroup
of
extracellular
vesicles
(EVs),
have
been
recognized
as
important
mediators
long
distance
intercellular
communication
and
are
involved
in
diverse
range
biological
processes.
Because
their
ideal
native
structure
characteristics,
exosomes
promising
nanocarriers
for
clinical
use.
Exosomes
engineered
at
the
cellular
level
under
natural
conditions,
but
successful
exosome
modification
requires
further
exploration.
The
focus
this
paper
is
to
summarize
passive
active
loading
approaches,
well
specific
modifications
examples
delivery
therapeutic
imaging
molecules.
Examples
derived
from
variety
origins
also
provided.
biocompatible
characteristics
exosomes,
with
suitable
modifications,
can
increase
stability
efficacy
probes
therapeutics
while
enhancing
uptake.
Challenges
translation
exosome-based
platforms
different
cell
sources
advantages
each
reviewed
discussed.
Signal Transduction and Targeted Therapy,
Journal Year:
2020,
Volume and Issue:
5(1)
Published: Aug. 5, 2020
Exosomes
are
extracellular
vesicles
secreted
by
most
eukaryotic
cells
and
participate
in
intercellular
communication.
The
components
of
exosomes,
including
proteins,
DNA,
mRNA,
microRNA,
long
noncoding
RNA,
circular
etc.,
which
play
a
crucial
role
regulating
tumor
growth,
metastasis,
angiogenesis
the
process
cancer
development,
can
be
used
as
prognostic
marker
and/or
grading
basis
for
patients.
Hereby,
we
mainly
summarized
followed:
exosome
contents
cancer,
focusing
on
proteins
RNA;
interaction
between
exosomes
microenvironment;
mechanisms
that
epithelial-mesenchymal
transition,
invasion
migration
affected
exosomes;
suppression
strategies
based
exosomes.
Finally,
application
potential
clinical
diagnosis
therapy
is
prospected,
providing
theoretical
supports
using
to
serve
precise
treatment
clinic.
Theranostics,
Journal Year:
2016,
Volume and Issue:
6(9), P. 1306 - 1323
Published: Jan. 1, 2016
With
the
unprecedented
progresses
of
biomedical
nanotechnology
during
past
few
decades,
conventional
drug
delivery
systems
(DDSs)
have
been
involved
into
smart
DDSs
with
stimuli-responsive
characteristics.
Benefiting
from
response
to
specific
internal
or
external
triggers,
those
well-defined
nanoplatforms
can
increase
targeting
efficacy,
in
meantime,
reduce
side
effects/toxicities
payloads,
which
are
key
factors
for
improving
patient
compliance.
In
academic
field,
variety
abundantly
demonstrated
various
intriguing
systems,
such
as
polymeric
nanoparticles,
liposomes,
metals/metal
oxides,
and
exosomes.
However,
these
lack
standardized
manufacturing
method,
toxicity
assessment
experience,
clear
relevance
between
pre-clinical
clinical
studies,
resulting
huge
difficulties
obtain
regulatory
ethics
approval.
Therefore,
relatively
complex
stimulus-sensitive
nano-DDSs
not
currently
approved
use.
this
review,
we
highlight
recent
advances
delivery.
Furthermore,
translation
obstacles
faced
by
reviewed
discussed.
We
also
present
future
directions
perspectives
stimuli-sensitive
DDS
applications.
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: May 31, 2021
Abstract
Cancer
is
a
disease
with
complex
pathological
process.
Current
chemotherapy
faces
problems
such
as
lack
of
specificity,
cytotoxicity,
induction
multi-drug
resistance
and
stem-like
cells
growth.
Nanomaterials
are
materials
in
the
nanorange
1–100
nm
which
possess
unique
optical,
magnetic,
electrical
properties.
used
cancer
therapy
can
be
classified
into
several
main
categories.
Targeting
cells,
tumor
microenvironment,
immune
system,
these
nanomaterials
have
been
modified
for
wide
range
therapies
to
overcome
toxicity
enhance
drug
capacity
well
bioavailability.
Although
number
studies
has
increasing,
approved
nano-drugs
not
increased
much
over
years.
To
better
improve
clinical
translation,
further
research
needed
targeted
delivery
by
nano-carriers
reduce
toxicity,
permeability
retention
effects,
minimize
shielding
effect
protein
corona.
This
review
summarizes
novel
fabricated
use,
discusses
current
limitations
obstacles
that
hinder
translation
from
provides
suggestions
more
efficient
adoption
therapy.